Decoy Therapeutics Inc.

Healthcare · Biotechnology · United States

Last price 1.23 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 805.88K

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design α-helical peptides through computational and ML tools. The company’s IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting ...